Pro Share Advisors LLC Amarin Corp Plcuk Transaction History

Pro Share Advisors LLC

  • $42.5 Billion
  • Q4 2024

A detailed history of Pro Share Advisors LLC transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Pro Share Advisors LLC holds 18,958 shares of AMRN stock, worth $7,772. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,958
Previous 23,646 19.83%
Holding current value
$7,772
Previous $14,000 35.71%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
SELL
$0.44 - $0.63 $2,062 - $2,953
-4,688 Reduced 19.83%
18,958 $9,000
Q3 2024

Nov 13, 2024
SELL
$0.57 - $0.8 $677 - $950
-1,188 Reduced 4.78%
23,646 $14,000
Q2 2024

Aug 13, 2024
SELL
$0.63 - $1.07 $1,389 - $2,360
-2,206 Reduced 8.16%
24,834 $17,000
Q1 2024

May 08, 2024
BUY
$0.82 - $1.35 $1,972 - $3,248
2,406 Added 9.77%
27,040 $24,000
Q4 2023

Feb 14, 2024
SELL
$0.66 - $0.91 $347 - $478
-526 Reduced 2.09%
24,634 $21,000
Q3 2023

Nov 13, 2023
BUY
$0.85 - $1.43 $244 - $411
288 Added 1.16%
25,160 $23,000
Q2 2023

Aug 10, 2023
SELL
$1.12 - $1.49 $1,798 - $2,392
-1,606 Reduced 6.07%
24,872 $29,000
Q1 2023

May 11, 2023
SELL
$1.19 - $2.19 $8,001 - $14,725
-6,724 Reduced 20.25%
26,478 $39,000
Q4 2022

Feb 02, 2023
SELL
$1.07 - $1.34 $71 - $89
-67 Reduced 0.2%
33,202 $40,000
Q3 2022

Nov 04, 2022
BUY
$1.09 - $1.67 $2,719 - $4,166
2,495 Added 8.11%
33,269 $36,000
Q2 2022

Aug 01, 2022
SELL
$1.13 - $3.69 $11,353 - $37,073
-10,047 Reduced 24.61%
30,774 $46,000
Q1 2022

May 10, 2022
SELL
$2.85 - $3.73 $40,393 - $52,865
-14,173 Reduced 25.77%
40,821 $134,000
Q4 2021

Feb 08, 2022
SELL
$3.24 - $5.18 $91,889 - $146,909
-28,361 Reduced 34.02%
54,994 $185,000
Q3 2021

Nov 12, 2021
BUY
$3.94 - $5.84 $52,441 - $77,730
13,310 Added 19.0%
83,355 $425,000
Q2 2021

Aug 13, 2021
BUY
$4.26 - $6.5 $69,599 - $106,197
16,338 Added 30.42%
70,045 $307,000
Q1 2021

May 14, 2021
SELL
$5.03 - $8.8 $28,580 - $50,001
-5,682 Reduced 9.57%
53,707 $334,000
Q4 2020

Feb 09, 2021
SELL
$4.04 - $5.31 $8,702 - $11,437
-2,154 Reduced 3.5%
59,389 $290,000
Q3 2020

Nov 13, 2020
BUY
$3.64 - $7.76 $15,892 - $33,880
4,366 Added 7.64%
61,543 $259,000
Q2 2020

Aug 03, 2020
BUY
$4.78 - $8.26 $39,850 - $68,863
8,337 Added 17.07%
57,177 $396,000
Q1 2020

May 15, 2020
SELL
$4.0 - $21.53 $111,152 - $598,275
-27,788 Reduced 36.26%
48,840 $195,000
Q4 2019

Feb 12, 2020
SELL
$13.94 - $24.12 $170,500 - $295,011
-12,231 Reduced 13.76%
76,628 $1.64 Million
Q3 2019

Nov 12, 2019
SELL
$13.89 - $23.16 $93,924 - $156,607
-6,762 Reduced 7.07%
88,859 $1.35 Million
Q2 2019

Aug 13, 2019
SELL
$16.27 - $20.51 $226,738 - $285,827
-13,936 Reduced 12.72%
95,621 $1.85 Million
Q1 2019

May 15, 2019
BUY
$12.61 - $22.33 $108,811 - $192,685
8,629 Added 8.55%
109,557 $2.27 Million
Q4 2018

Feb 14, 2019
SELL
$12.41 - $22.98 $223,007 - $412,950
-17,970 Reduced 15.11%
100,928 $1.37 Million
Q3 2018

Nov 14, 2018
SELL
$2.45 - $16.27 $8,550 - $56,782
-3,490 Reduced 2.85%
118,898 $1.93 Million
Q2 2018

Aug 13, 2018
SELL
$2.68 - $3.48 $5,397 - $7,008
-2,014 Reduced 1.62%
122,388 $378,000
Q1 2018

May 14, 2018
SELL
$2.99 - $4.44 $61,061 - $90,673
-20,422 Reduced 14.1%
124,402 $374,000
Q4 2017

Feb 14, 2018
SELL
$3.06 - $4.09 $11,637 - $15,554
-3,803 Reduced 2.56%
144,824 $581,000
Q3 2017

Nov 13, 2017
BUY
$3.03 - $3.72 $40,580 - $49,821
13,393 Added 9.9%
148,627 $520,000
Q2 2017

Aug 11, 2017
BUY
N/A
135,234
135,234 $545,000

Others Institutions Holding AMRN

# of Institutions
183
Shares Held
71.2M
Call Options Held
183K
Put Options Held
66.7K
View Full List

About AMARIN CORP PLCUK

AMRN Quotes by TradingView
  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $165M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email